Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
73 /100
HIGH RISK
Score updated Oct 13, 2026

KLRS — Kalaris Therapeutics, Inc. Dilution Risk Tracker

Track KLRS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KLRS — Get alerts when the score changes →

As of October 13, 2026, Kalaris Therapeutics, Inc. (KLRS) has a DilutionWatch DilutionScore of 73/100, rated HIGH dilution risk. Kalaris Therapeutics, Inc. has a market capitalization of $53.80M, 23.80M shares outstanding, 58 institutional holders tracked. Stored dilution-related fields include 800.0K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
65
📊 Float Risk
70
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 10%
💰 Capital Raise model 15%
• Under 12 months cash (12mo)
📉 Score Deterioration model 10%
• Score in HIGH risk zone (73/100)
🔔 Track KLRS — Get forecast alerts →

Market Data

Market Cap$53.80M
Shares Outstanding23.80M
Float6.57M
Cash$93.54M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore73/100DilutionWatch score record
Shares Outstanding23.80MVerified float table or market cache
Public Float6.57MVerified float table or market cache
Market Cap$53.80MMarket data cache
Cash Runway11.8 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants800.0KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 4.

Recent SEC source mix: 4 2, 8-K 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 5.8% shares (2026Q1 vs prior)
58 institutional holders · 19.17M shares
#1 SAMSARA BIOCAPITAL, LLC 12.95M shares
#2 RTW INVESTMENTS, LP 1.30M shares
#3 Paradigm Biocapital Advisors LP 700.0K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest331.9K
Days to Cover4.6
% of Float5.0%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-17
4 INSIDER TRANSACTION 2026-02-17
4 INSIDER TRANSACTION 2025-12-22
8-K 8K EVENT 2025-12-18
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual KLRS Dilution Snapshot

Kalaris Therapeutics, Inc. (KLRS) has a DilutionScore of 73/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

KLRS's DilutionScore is currently 73/100 (High risk), with 2 score changes tracked over 89 days. The score improved from 66/100 (High risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202673/100HIGH53 days
Jul 17 – Aug 21, 202666/100HIGH35 days
Jul 16, 202667/100HIGH1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

KLRS shares outstanding have increased 27.2% from 18.70M (Mar 2026) to 23.79M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 14, 202623.79M6.57M▲ 3.47%
May 06, 202622.99M6.35M▲ 0.73%
May 01, 202622.99M6.31M▲ 4.17%
Apr 10, 202622.93M6.05M▲ 0.03%
Mar 23, 202622.93M6.05M▲ 231.31%
Mar 22, 202622.93M1.83M▼ 3.86%
Mar 19, 202618.70M1.90M▲ 4.02%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track KLRS Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment KLRS files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking KLRS — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for KLRS
KLRS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.